Insights into MMP-TIMP interactions

Bode W, Fernandez-Catalan C, Grams F, Gomis-Ruth FX, Nagase H, Tschesche H, Maskos K (1999)
In: INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC APPLICATIONS. 878. NEW YORK ACAD SCIENCES: 73-91.

Conference Paper | Published | English

No fulltext has been uploaded

Author
; ; ; ; ; ;
Abstract
The proteolytic activity of the matrix metalloproteinases (MMPs) involved in extracellular matrix degradation must be precisely regulated by their endogenous protein inhibitors, the tissue inhibitors of metalloproteinases (TIMPs). Disruption of this balance can result in serious diseases such as arthritis and tumor growth and metastasis, Knowledge of the tertiary structures of the proteins involved in such processes is crucial for understanding their functional properties and to interfere with associated dysfunctions, Within the last few years, several three-dimensional structures have been determined showing the domain organization, the polypeptide fold, and the main specificity determinants of the MMPs. Complexes of the catalytic MMP domains with various synthetic inhibitors enabled the structure-based design and improvement of high-affinity ligands, which might be elaborated into drugs, Very recently, structural information also became available for some TIMP structures and MMP-TIMP complexes, and these new data elucidated important structural features that govern the enzyme-inhibitor interaction.
Publishing Year
ISSN
PUB-ID

Cite this

Bode W, Fernandez-Catalan C, Grams F, et al. Insights into MMP-TIMP interactions. In: INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC APPLICATIONS. Vol 878. NEW YORK ACAD SCIENCES; 1999: 73-91.
Bode, W., Fernandez-Catalan, C., Grams, F., Gomis-Ruth, F. X., Nagase, H., Tschesche, H., & Maskos, K. (1999). Insights into MMP-TIMP interactions. INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC APPLICATIONS, 878, 73-91.
Bode, W., Fernandez-Catalan, C., Grams, F., Gomis-Ruth, F. X., Nagase, H., Tschesche, H., and Maskos, K. (1999). “Insights into MMP-TIMP interactions” in INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC APPLICATIONS, vol. 878, (NEW YORK ACAD SCIENCES), 73-91.
Bode, W., et al., 1999. Insights into MMP-TIMP interactions. In INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC APPLICATIONS. no.878 NEW YORK ACAD SCIENCES, pp. 73-91.
W. Bode, et al., “Insights into MMP-TIMP interactions”, INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC APPLICATIONS, vol. 878, NEW YORK ACAD SCIENCES, 1999, pp.73-91.
Bode, W., Fernandez-Catalan, C., Grams, F., Gomis-Ruth, F.X., Nagase, H., Tschesche, H., Maskos, K.: Insights into MMP-TIMP interactions. INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC APPLICATIONS. 878, p. 73-91. NEW YORK ACAD SCIENCES (1999).
Bode, W, Fernandez-Catalan, C, Grams, F, Gomis-Ruth, FX, Nagase, H, Tschesche, Harald, and Maskos, K. “Insights into MMP-TIMP interactions”. INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC APPLICATIONS. NEW YORK ACAD SCIENCES, 1999.Vol. 878. 73-91.
This data publication is cited in the following publications:
This publication cites the following data publications:

45 Citations in Europe PMC

Data provided by Europe PubMed Central.

Loss of Endothelial Barrier in Marfan Mice (mgR/mgR) Results in Severe Inflammation after Adenoviral Gene Therapy.
Seppelt PC, Schwill S, Weymann A, Arif R, Weber A, Zaradzki M, Richter K, Ensminger S, Robinson PN, Wagner AH, Karck M, Kallenbach K., PLoS ONE 11(2), 2016
PMID: 26840980
SPR Biosensor Probing the Interactions between TIMP-3 and Heparin/GAGs.
Zhang F, Lee KB, Linhardt RJ., Biosensors (Basel) 5(3), 2015
PMID: 26213979
Caffeic Acid phenethyl ester is a potential therapeutic agent for oral cancer.
Kuo YY, Jim WT, Su LC, Chung CJ, Lin CY, Huo C, Tseng JC, Huang SH, Lai CJ, Chen BC, Wang BJ, Chan TM, Lin HP, Chang WS, Chang CR, Chuu CP., Int J Mol Sci 16(5), 2015
PMID: 25984601
Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in amyotrophic lateral sclerosis (ALS).
Lukaszewicz-Zajac M, Mroczko B, Slowik A., J Neural Transm (Vienna) 121(11), 2014
PMID: 25047909
Tissue inhibitor of metalloproteinase gene from pearl oyster Pinctada martensii participates in nacre formation.
Yan F, Jiao Y, Deng Y, Du X, Huang R, Wang Q, Chen W., Biochem. Biophys. Res. Commun. 450(1), 2014
PMID: 24942875
Glia ECM interactions are required to shape the Drosophila nervous system.
Meyer S, Schmidt I, Klambt C., Mech. Dev. 133(), 2014
PMID: 24859129
The endogenous protease inhibitor TIMP-1 mediates protection and recovery from cutaneous photodamage.
Yokose U, Hachiya A, Sriwiriyanont P, Fujimura T, Visscher MO, Kitzmiller WJ, Bello A, Tsuboi R, Kitahara T, Kobinger GP, Takema Y., J. Invest. Dermatol. 132(12), 2012
PMID: 22718114
Salivary tissue inhibitor of metalloproteinases-1 localization and glycosylation profile analysis.
Holten-Andersen L, Thaysen-Andersen M, Jensen SB, Buchwald C, Hojrup P, Offenberg H, Nielsen HJ, Brunner N, Nauntofte B, Reibel J., APMIS 119(11), 2011
PMID: 21995626
Expression of matrix metalloproteinases and their tissue inhibitors in the serum and cerebrospinal fluid of patients with meningitis.
Tsai HC, Shi MH, Lee SS, Wann SR, Tai MH, Chen YS., Clin. Microbiol. Infect. 17(5), 2011
PMID: 21521415
MMP-2 expression precedes the final ripening process of the bovine cervix.
van Engelen E, Breeveld-Dwarkasing VN, Taverne MA, Everts ME, van der Weijden GC, Rutten VP., Mol. Reprod. Dev. 75(11), 2008
PMID: 18361420
Human TNF-alpha gene vaccination prevents collagen-induced arthritis in mice.
Shen Y, Chen J, Zhang X, Wu X, Xu Q., Int. Immunopharmacol. 7(9), 2007
PMID: 17630192
Modulation of matrix gelatinases and metalloproteinase-activating process in acute kidney rejection.
Laplante A, Liu D, Demeule M, Annabi B, Murphy GF, Daloze P, Chen H, Beliveau R., Transpl. Int. 16(4), 2003
PMID: 12730807
Phenotypic alterations in Caki-1 cells as a consequence of TIMP-1 overexpression.
Reid HM, McElligott AM, McGlynn H., Cancer Lett. 169(2), 2001
PMID: 11431108

71 References

Data provided by Europe PubMed Central.

Structure of full-length porcine synovial collagenase reveals a C-terminal domain containing a calcium-linked, four-bladed beta-propeller.
Li J, Brick P, O'Hare MC, Skarzynski T, Lloyd LF, Curry VA, Clark IM, Bigg HF, Hazleman BL, Cawston TE., Structure 3(6), 1995
PMID: 8590015
Structure of the catalytic domain of human fibroblast collagenase complexed with an inhibitor.
Borkakoti N, Winkler FK, Williams DH, D'Arcy A, Broadhurst MJ, Brown PA, Johnson WH, Murray EJ., Nat. Struct. Biol. 1(2), 1994
PMID: 7656013
The NMR structure of the inhibited catalytic domain of human stromelysin-1.
Gooley PR, O'Connell JF, Marcy AI, Cuca GC, Salowe SP, Bush BL, Hermes JD, Esser CK, Hagmann WK, Springer JP., Nat. Struct. Biol. 1(2), 1994
PMID: 7656014
Structure of human neutrophil collagenase reveals large S1' specificity pocket.
Stams T, Spurlino JC, Smith DL, Wahl RC, Ho TF, Qoronfleh MW, Banks TM, Rubin B., Nat. Struct. Biol. 1(2), 1994
PMID: 7656015
Crystal structure of the haemopexin-like C-terminal domain of gelatinase A.
Libson AM, Gittis AG, Collier IE, Marmer BL, Goldberg GI, Lattman EE., Nat. Struct. Biol. 2(11), 1995
PMID: 7583664
Structure of astacin with a transition-state analogue inhibitor.
Grams F, Dive V, Yiotakis A, Yiallouros I, Vassiliou S, Zwilling R, Bode W, Stocker W., Nat. Struct. Biol. 3(8), 1996
PMID: 8756323
Activation of human neutrophil procollagenase by stromelysin 2.
Knauper V, Murphy G, Tschesche H., Eur. J. Biochem. 235(1-2), 1996
PMID: 8631328
Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity.
Docherty AJ, Lyons A, Smith BJ, Wright EM, Stephens PE, Harris TJ, Murphy G, Reynolds JJ., Nature 318(6041), 1985
PMID: 3903517
Structural basis of the action of thermolysin and related zinc peptidases
Matthews, Accounts of Chemical Research 21(9), 1988
The N-terminal domain of tissue inhibitor of metalloproteinases retains metalloproteinase inhibitory activity.
Murphy G, Houbrechts A, Cockett MI, Williamson RA, O'Shea M, Docherty AJ., Biochemistry 30(33), 1991
PMID: 1868085
Comparative sequence specificities of human 72- and 92-kDa gelatinases (type IV collagenases) and PUMP (matrilysin).
Netzel-Arnett S, Sang QX, Moore WG, Navre M, Birkedal-Hansen H, Van Wart HE., Biochemistry 32(25), 1993
PMID: 8390857
Mutation of the active site glutamic acid of human gelatinase A: effects on latency, catalysis, and the binding of tissue inhibitor of metalloproteinases-1.
Crabbe T, Zucker S, Cockett MI, Willenbrock F, Tickle S, O'Connell JP, Scothern JM, Murphy G, Docherty AJ., Biochemistry 33(21), 1994
PMID: 7911325
Crystal structures of recombinant 19-kDa human fibroblast collagenase complexed to itself.
Lovejoy B, Hassell AM, Luther MA, Weigl D, Jordan SR., Biochemistry 33(27), 1994
PMID: 8031754
Structure determination and analysis of human neutrophil collagenase complexed with a hydroxamate inhibitor.
Grams F, Crimmin M, Hinnes L, Huxley P, Pieper M, Tschesche H, Bode W., Biochemistry 34(43), 1995
PMID: 7577999
Matrilysin-inhibitor complexes: common themes among metalloproteases.
Browner MF, Smith WW, Castelhano AL., Biochemistry 34(20), 1995
PMID: 7756291
Matrix metalloproteinase inhibitors 1998
Beckett, Expert Opinion on Therapeutic Patents 8(3), 1998
1.56 A structure of mature truncated human fibroblast collagenase.
Spurlino JC, Smallwood AM, Carlton DD, Banks TM, Vavra KJ, Johnson JS, Cook ER, Falvo J, Wahl RC, Pulvino TA., Proteins 19(2), 1994
PMID: 8090713
On the size of the active site in proteases. I. Papain.
Schechter I, Berger A., Biochem. Biophys. Res. Commun. 27(2), 1967
PMID: 6035483
Computational sequence analysis of matrix metalloproteinases.
Sang QA, Douglas DA., J. Protein Chem. 15(2), 1996
PMID: 8924199
Structure of the catalytic domain of fibroblast collagenase complexed with an inhibitor.
Lovejoy B, Cleasby A, Hassell AM, Longley K, Luther MA, Weigl D, McGeehan G, McElroy AB, Drewry D, Lambert MH., Science 263(5145), 1994
PMID: 8278810

Export

0 Marked Publications

Open Data PUB

Web of Science

View record in Web of Science®

Sources

PMID: 10415721
PubMed | Europe PMC

Search this title in

Google Scholar